atai Life Sciences (ATAI) Misses Q4 EPS by 9c

atai Life Sciences (NASDAQ: ATAI) reported Q4 EPS of ($0.24), $0.09 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Bending Spoons closes $1.25B term loan add-on to fund Miro deal
• Krait Critical Minerals closes $1.22M first tranche of placement